menu search

AZTA / Azenta, Inc. (AZTA) CEO Steve Schwartz on Q3 2022 Results - Earnings Call Transcript

Azenta, Inc. (AZTA) CEO Steve Schwartz on Q3 2022 Results - Earnings Call Transcript
Azenta, Inc. (NASDAQ:AZTA ) Q3 2022 Earnings Conference Call August 9, 2022 4:30 PM ET Company Participants Sara Silverman - Director, IR Steve Schwartz - President & CEO Lindon Robertson - EVP & CFO Matt McManus - COO Conference Call Participants Jacob Johnson - Stephens Paul Knight - KeyBanc Vijay Kumar - Evercore ISI David Saxon - Needham Yuan Zhi - B. Riley Securities Operator Greetings, and welcome to the Azenta Q3 2022 Financial Results. Read More
Posted: Aug 9 2022, 22:33
Author Name: Seeking Alpha
Views: 110661

AZTA News  

You Can't Control Activist Investors, but You Can Control What You Do About Them

By The Motley Fool
October 12, 2023

You Can't Control Activist Investors, but You Can Control What You Do About Them

Having activist investors at a company can lead to big changes. Azenta is dealing with an activist's call for better performance as it puts a giant ca more_horizontal

Activist Politan Capital engages with Azenta. Here's how the firm may boost shareholder value

By CNBC
September 30, 2023

Activist Politan Capital engages with Azenta. Here's how the firm may boost shareholder value

Azenta is sitting on a pile of cash, and shareholders will want to know the company's plans for the money. more_horizontal

Robo-Lab Stocks: 3 Robotics Companies Changing the Research Game

By InvestorPlace
September 4, 2023

Robo-Lab Stocks: 3 Robotics Companies Changing the Research Game

Here's a look at 3 leading robo-lab company stocks. When you think of dexterous professions, you often think of doctors or musicians. more_horizontal

Biotech Bonanza: 3 Top DNA Stocks With Revolutionary Potential

By InvestorPlace
August 11, 2023

Biotech Bonanza: 3 Top DNA Stocks With Revolutionary Potential

DNA is as fundamental to biotechnology as it is to biology itself. From synthetic biology to pharmaceuticals, making and using DNA is usually a necess more_horizontal

Azenta: A Second Assessment

By Seeking Alpha
June 16, 2023

Azenta: A Second Assessment

Today, we take our second look at a life sciences concern called Azenta, Inc. The company has a massive cash hoard, is buying back a huge amount of st more_horizontal

Azenta, Inc. (AZTA) Q2 2023 Earnings Call Transcript

By Seeking Alpha
May 9, 2023

Azenta, Inc. (AZTA) Q2 2023 Earnings Call Transcript

Azenta, Inc. (NASDAQ:AZTA ) Q2 2023 Earnings Conference Call May 9, 2023 4:30 PM ET Company Participants Sara Silverman - Head, IR & Corporate Communi more_horizontal

Azenta, Inc. (AZTA) Q1 2023 Earnings Call Transcript

By Seeking Alpha
February 10, 2023

Azenta, Inc. (AZTA) Q1 2023 Earnings Call Transcript

Azenta, Inc. (NASDAQ:AZTA ) Q1 2023 Earnings Conference Call February 8, 2023 4:30 PM ET Company Participants Sara Silverman - Head, IR Stephen Schwar more_horizontal

Azenta (AZTA) Beats Q1 Earnings Estimates

By Zacks Investment Research
February 8, 2023

Azenta (AZTA) Beats Q1 Earnings Estimates

Brooks (AZTA) delivered earnings and revenue surprises of 100% and 1.90%, respectively, for the quarter ended December 2022. Do the numbers hold clues more_horizontal


Search within

Pages Search Results: